| Synonyms: | |
| Status: | Phase 2 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| UNII: | ZXM835LQ5E |
| InChI Key | AXTAPYRUEKNRBA-JTQLQIEISA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C18H16Cl2F2N4O2 |
| Molecular Weight | 429.25 |
| AlogP | 3.56 |
| Hydrogen Bond Acceptor | 5.0 |
| Hydrogen Bond Donor | 2.0 |
| Number of Rotational Bond | 6.0 |
| Polar Surface Area | 86.08 |
| Molecular species | BASE |
| Aromatic Rings | 3.0 |
| Heavy Atoms | 28.0 |
| Action | Mechanism of Action | Reference |
|---|---|---|
| INHIBITOR | Serine/threonine-protein kinase AKT inhibitor | PubMed |
| Primary Target | |
|---|---|
| AKT serine/threonine kinase 1 | |
| AKT serine/threonine kinase 2 | |
| AKT serine/threonine kinase 3 |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Leukemia, Myeloid, Acute | 2 | D015470 | ClinicalTrials |
| Multiple Myeloma | 2 | D009101 | ClinicalTrials |
| Uterine Cervical Neoplasms | 2 | D002583 | ClinicalTrials |
| Melanoma | 2 | D008545 | ClinicalTrials |
| Breast Neoplasms | 2 | D001943 | ClinicalTrials |
| Neoplasms | 1 | D009369 | ClinicalTrials |
| Neoplasms | 1 | D009369 | ClinicalTrials |
| Resources | Reference |
|---|---|
| CAS NUMBER | 1047634-65-0 |
| ChEMBL | CHEMBL3137336 |
| DrugBank | DB11969 |
| FDA SRS | ZXM835LQ5E |
| Guide to Pharmacology | 7902 |
| PubChem | 51042438 |
| SureChEMBL | SCHEMBL168584 |
| ZINC | ZINC000043197676 |